Get started
Keyword

HER2 expression

Description: HER2 expression is the production or presence of HER2 RNA or protein in cells, assessed in cancer diagnosis and treatment research.
OpenAlex ID: keywords/her2-expression
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
2022 · Shanu Modi, William Jacot, et al. · New England Journal of Medicine · 2,677
PDF
Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer
2021 · Bob T. Li, Egbert F. Smit, et al. · New England Journal of Medicine · 1,025
PDF
Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
2009 · A. A. Onitilo, J. M. Engel, et al. · Clinical Medicine & Research · 839
PDF
HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues
2004 · Marilyn A. Owens, Bruce C. Horten, et al. · Clinical Breast Cancer · 657
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
2018 · Bob T. Li, Ronglai Shen, et al. · Journal of Clinical Oncology · 557
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017 · M.J. Duffy, N. Harbeck, et al. · European Journal of Cancer · 522
PDF
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
2010 · Sabine Riethdorf, Volkmar Müller, et al. · Clinical Cancer Research · 490
HER2 expression identifies dynamic functional states within circulating breast cancer cells
2016 · Nicole Vincent Jordan, Aditya Bardia, et al. · Nature · 406
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
2023 · Fernanda Mosele, Elise Deluche, et al. · Nature Medicine · 403
PDF
Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
1991 · Y Yonemura, I Ninomiya, et al. · PubMed · 333
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001 · S Geisler, P E Lønning, et al. · PubMed · 326
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
2004 · U. Gatzemeier, A. Pluzanska, et al. · Journal of Clinical Oncology · 312
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
2006 · S Banerjee, J S Reis-Filho, et al. · Journal of Clinical Pathology · 290
PDF
Microvessel Density and Distribution in Ductal Carcinoma In Situ of the Breast
1994 · A. J. Guidi, L. Fischer, et al. · JNCI Journal of the National Cancer Institute · 284
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer
2010 · Sarah Minner, Corinna Wittmer, et al. · The Prostate · 283
Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
2009 · Janna Paulsson, Tobias Sjöblom, et al. · American Journal Of Pathology · 266
PDF
HER2 Expression in Gastric Cancer: Rare, Heterogeneous and of No Prognostic Value – Conclusions from 924 Cases of Two Independent Series
2010 · Heike Grabsch, Shivan Sivakumar, et al. · Analytical Cellular Pathology · 263
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
2004 · Sunil R. Lakhani, Sanjiv Manek, et al. · Clinical Cancer Research · 252
Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
2012 · Chunling Ma, Qunyuan Zhang, et al. · The Journal of Immunology · 214
Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC
2003 · Federico Cappuzzo, Vanesa Gregorc, et al. · Journal of Clinical Oncology · 212
HER2-Positive Circulating Tumor Cells in Breast Cancer
2011 · Michail Ignatiadis, Françoise Rothé, et al. · PLoS ONE · 203
PDF
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
2003 · Robert L Camp, Marisa Dolled-Filhart, et al. · PubMed · 199
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
2015 · Maggie C.U. Cheang, Miguel Martin, et al. · The Oncologist · 194
PDF
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
2012 · Michael Rink, Felix K. Chun, et al. · European Urology · 190
Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients
2007 · John F. Smyth, Charlie Gourley, et al. · Clinical Cancer Research · 189
Works count: 3,815
Citation count: 41,610
Year
Topic
Type